Gene Data From HGNC: https://www.genenames.org/download/statistics-and-files/
Symbol:
LPA
Name:
lipoprotein(a)
Location:
06q25.3-q26
Locus Group:
protein-coding gene
Gene Type:
Protein Coding
Locus Type:
gene with protein product
Clinical Trials Data: https://classic.clinicaltrials.gov/api/gui/ref/download_all
Clinical Studies
| NCT Number | Status | Brief Title | View |
|---|---|---|---|
| NCT00257907 | Immune Response to Mycobacterium Tuberculosis Infection | View | |
| NCT02628275 | Impact of Mild or Moderate Physical Activity and Progression of Subclinical Atherosclerosis | View | |
| NCT00465933 | Treatment of Acute Promyelocytic Leukemia With All-Trans Retinoic Acid ATRA and Idarubicin AIDA | View | |
| NCT06467058 | Convergent Validity of DABQ Questionnaire | View | |
| NCT04247048 | Kinetic Study of Lpa and PCSK9 in Humans | View | |
| NCT02215278 | A Multiple Meal Stable Iron Isotope Study in Iron Deficient Rwandese Women to Investigate the Performance of Low Phytic Acid Bean Seeds | View | |
| NCT02677857 | Developing a Healthy Lifestyle in Breast Cancer Survivors | View | |
| NCT02791802 | Effect of Lipoproteina Elimination by Lipoprotein Apheresis on Cardiovascular Outcomes | View | |
| NCT02894060 | A Study of Immunological Biomarkers as Predictors of Cardiovascular Events | View | |
| NCT02976818 | Lpa and Aortic Valve Calcification | View | |
| NCT05962827 | Testing for Increased Lipoproteins a LPa in Lymphedema Patients Li-LY | View | |
| NCT04147676 | Evaluation of Centralised TB Assay Solutions | View | |
| NCT00820313 | A Prospective Evaluation of Health Services Outcomes and Emerging Cardiovascular Disease Biomarkers | View | |
| NCT04579367 | Treatment With Bempedoic Acid andor Its Fixed-dose Combination With Ezetimibe in Primary Hypercholesterolemia or Mixed Dyslipidemia | View | |
| NCT04671719 | Determination of Circulating Autotaxin in Patients With GNAS or PTH Abnormalities | View | |
| NCT06297239 | Argentine Registry of Lpa | View | |
| NCT04968509 | Effect of PCSK9 Inhibitors on Calcific Aortic Valve Stenosis | View | |
| NCT04987320 | A Study to Evaluate the Pharmacokinetics Pharmacodynamics Safety and Tolerability of Olpasiran in Chinese Participants With Elevated Serum Lipoproteina | View | |
| NCT05181969 | Long-term Characterization of Lipoprotein Apheresis Technologies for Individual Device Adaption LOLIDA | View | |
| NCT06610669 | The Prevalence of Hyper-Lpa-Emia in the PMMHRI-Lpa Registry | View | |
| NCT02109614 | Early Aortic Valve Lipoproteina Lowering Trial | View | |
| NCT05505942 | Physical Activity for PLWH and Unhealthy Drinking | View | |
| NCT05565742 | A Study of LY3819469 in Participants With Elevated Lipoproteina Lpa | View | |
| NCT06482476 | Medical Students Evaluation of Dyslipidemia and LIPoproteina Study | View | |
| NCT05988866 | Effects of a Digital Health Application Lipodia on LDL-cholesterol Levels | View | |
| NCT04350216 | Effect of Sarilumab on Atherosclerotic Disease Assessed by PETCET in Patients With RA SARIPET | View | |
| NCT01690312 | Clinical Study to Assess High-DHA Fish Oil on Biomarkers of Cardiovascular Disease Risk in Adults on Statin Therapy | View | |
| NCT01290770 | Search a Correlation Between Lpa Rate and TFPI Activity in Obese Patients With Chest Pain Like Angina | View | |
| NCT02715726 | Evaluation of Alirocumab Versus Ezetimibe on Top of Statin in Asia in High Cardiovascular Risk Patients With Hypercholesterolemia | View | |
| NCT01472484 | Impact of Bean Polyphenols and Phytic Acid on Iron Absorption | View | |
| NCT01796912 | Lipoprotein Apheresis in Refractory Angina Study | View | |
| NCT00626223 | 5-methyltetrahydrofolate Survival and Inflammation in ESRD Patients | View | |
| NCT01556906 | Safety Tolerability and Efficacy of Microsomal Triglyceride Protein MTP Inhibitor | View | |
| NCT02740634 | Molecular and Structural Imaging in Alzheimers Disease A Longitudinal Study | View | |
| NCT01651143 | Proof of Biological Activity of SAR100842 in Systemic Sclerosis | View | |
| NCT02225340 | Relationships Between Plasma PCSK9 Levels LDL-cholesterol Concentrations and Lipoprotein a Levels in Familial Hypercholesterolemia | View | |
| NCT02241772 | A Study on the Effects of TA-8995 on Lpa in Subjects With Elevated Lpa | View | |
| NCT01723553 | Amyloid-related Imaging Abnormalities Microbleeds in Atypical AD | View | |
| NCT01178515 | Low Fat Milk Intake and Cardio Vascular Risk CVR Indicators in Children | View | |
| NCT01727596 | The Effects and Predictors of Patella Taping in the Treatment of Patellafemoral Pain Syndrome | View | |
| NCT02380534 | Use of Apheretic Technologies in Cardiovascular Disease | View | |
| NCT04270760 | Olpasiran Trials of Cardiovascular Events And LipoproteiNa Reduction - DOSE Finding Study | View | |
| NCT02705898 | Lifestyle Physical Activity Intervention for Depressed Alcohol Dependent Women | View | |
| NCT04914546 | A Study of LY3819469 in Healthy Participants | View | |
| NCT04993664 | Influence of Pelacarsen on Patients After Myocardial Infarction With High Lpa Values PEMILA | View | |
| NCT05090878 | Atherogenic Lipoproteins in Ischemic Stroke | View | |
| NCT02515747 | Prospective Russian Evaluation of Lpa Role in cardiovascUlar DiseasE | View | |
| NCT05367570 | 24-hour Movement Behaviors Among Normal Weight Overweight and Obese Adults | View | |
| NCT05378529 | A Cross-sectional Study of Lipoproteina Levels in Patients With Documented History of Atherosclerotic Cardiovascular Disease ASCVD | View | |
| NCT04100122 | Luminex-based Assay to Identify Major IgE-binding Episode Among IgE-mediated Wheat-allergic Patient | View | |
| NCT05586516 | A Study to Assess an ATX Inhibitor IOA-289 in Patients With Metastatic Pancreatic Cancer | View | |
| NCT02584504 | Efficacy and Safety of Alirocumab in Patients With Hypercholesterolemia Not Adequately Controlled With Non-statin Lipid Modifying Therapy or the Lowest Strength of Statin | View | |
| NCT02729025 | Effects of Proprotein Convertase SubtilisinKexin Type 9 PCSK9 Inhibition on Arterial Wall Inflammation in Patients With Elevated Lipoproteina Lpa | View | |
| NCT04284735 | Lysophosphatidic Acid Autotaxin Axis in Rheumatoid Lung Disease | View | |
| NCT02952638 | Dietary Sources of Lysophospholipids | View | |
| NCT03070782 | Phase 2 Study of ISIS 681257 AKCEA-APOa-LRx in Participants With Hyperlipoproteinemiaa and Cardiovascular Disease | View | |
| NCT03172611 | A Defined Plant-based 4-week Dietary Intervention Reduces Lpa and Other Atherogenic Particles | View | |
| NCT03236597 | Assessing the Effects Of Treadmill On LPA Sitting Time and Cardiovascular Risk | View | |
| NCT04531163 | Possible Ameliorating Effect of N- Acetylcysteine NAC on Type-II Diabetes Induced Nephropathy | View | |
| NCT06267560 | Lpa Lowering Study of Pelacarsen TQJ230 in US BlackAfrican American and Hispanic Participants With Elevated Lpa and Established ASCVD | View | |
| NCT03626662 | Safety Tolerability Pharmacokinetics and Pharmacodynamics Study of AMG 890 in Subjects With Elevated Plasma Lipoproteina | View | |
| NCT03771417 | Resistance Exercise and Low-Intensity Physical Activity Breaks in Sedentary Time to Improve Muscle and Cardiometabolic Health | View | |
| NCT04993482 | 24-hour Movement Behaviors Among Type 2 Diabetes Mellitus Patients | View | |
| NCT05496790 | Role of LipoprotEina in CardiovascuLar Diseases and Premature Acute Coronary Syndromes - RELACS Study | View | |
| NCT04023552 | Assessing the Impact of Lipoprotein a Lowering With Pelacarsen TQJ230 on Major Cardiovascular Events in Patients With CVD | View | |
| NCT05043740 | PCSK9 Inhibitor on ACS Patients With Multivessel Disease and Relatively Low LDL-C Level in Chinese Population | View | |
| NCT04233918 | Evaluate the Efficacy and Safety of Evinacumab in Pediatric Patients With Homozygous Familial Hypercholesterolemia | View | |
| NCT04268160 | GPx Activity in Subjects With Aortic Stenosis Undergoing TAVR | View | |
| NCT06014060 | 24 Versus 12-Month Dual Antiplatelet Therapy After Drug-Eluting Stent in Patients With Elevated Lipoproteina Levels | View | |
| NCT04606602 | Study to Investigate Safety Tolerability PK and PD Response of SLN360 in Subjects With Elevated Lipoproteina | View | |
| NCT04667520 | Testing a Lifestyle Physical Activity Intervention for Women With Depression in Alcohol Treatment | View | |
| NCT04897490 | RWE of 1st Line Treatment With ATOATRA for Adult APL | View | |
| NCT05027568 | A Study to Assess an ATX Inhibitor IOA-289 in Healthy Volunteers | View | |
| NCT05031065 | Prognostic Indicators for Radiation-induced Breast Fibrosis | View | |
| NCT05079256 | Laser Induced Changes to Innervation and Vascularisation of Psoriatic Skin | View | |
| NCT06304415 | Elevated Lipoproteina in Hospital Staff | View | |
| NCT05323227 | Lpa With CCTA Assessed Parameters and Clinical Outcomes | View | |
| NCT06648915 | Lipoproteina and Progression of Aortic Stenosis | View | |
| NCT06548399 | Longitudinal Study on Bacterial Production of LPC and LPA in Patients With Inflammatory Bowel Disease | View | |
| NCT00633698 | Evaluation of the Effect of NICOtinic Acid Niacin on Elevated Lipoproteina Levels NICOLa Study | View | |
| NCT05563246 | A Study of LY3473329 in Adult Participants With Elevated Lipoproteina at High Risk for Cardiovascular Events | View | |
| NCT01959971 | Effect of Alirocumab on Lipid Metabolism in Adults With Elevated LDL-Cholesterol | View | |
| NCT06626659 | Lipoprotein a and Vascular Regenerative Cell Content | View | |
| NCT00712049 | Effects of Nicotinic Acid Plus Simvastatin Versus Simvastatin Alone on Carotid and Femoral Intima-Media Thickness in Patients With Peripheral Artery Disease NASCIT | View | |
| NCT05646381 | A Multicenter Trial Assessing the Impact of Lipoproteina Lowering With Pelacarsen TQJ230 on the Progression of Calcific Aortic Valve Stenosis | View | |
| NCT01985048 | Cardiometabolic Risk in Cardiac Rehab | View | |
| NCT00853775 | Family Research Study Metabolism of Fats and Proteins in Specific Ethnic Groups | View | |
| NCT01095744 | Influence of Age on Amyloid Load in Alzheimers Disease and in Atypical Focal Cortical Alzheimers Disease | View | |
| NCT06126367 | Assessment of Lipoproteina and Endogenous Fibrinolysis in Atherosclerotic Cardiovascular DiseaseAortic Valve Disease | View | |
| NCT02585778 | Efficacy and Safety of Alirocumab Versus Placebo on Top of Maximally Tolerated Lipid Lowering Therapy in Patients With Hypercholesterolemia Who Have Type 1 or Type 2 Diabetes and Are Treated With Insulin ODYSSEY DM - Insulin | View | |
| NCT06157983 | Evaluation of Cascade Screening for Elevated Lipoproteina | View | |
| NCT06239701 | Development of a Lifestyle Physical Activity Intervention to Reduce Risk for Perinatal Cannabis Use - RCT | View | |
| NCT01321034 | Effect of Niacin in the Lipoprotein a Concentration | View | |
| NCT06496243 | Impact of Obicetrapib and Obicetrapib Plus Repatha on Lpa Levels | View | |
| NCT01064934 | Randomized Controlled Trial of Lipid Apheresis in Patients With Elevated Lipoproteina | View | |
| NCT06292013 | A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoproteina - ACCLAIM-Lpa | View | |
| NCT02133807 | Specific Lpa Apheresis for Regression of Coronary and Carotid Atherosclerosis | View | |
| NCT00005368 | Genetic Epidemiology of Hypertriglyceridemia | View | |
| NCT00001938 | A Pilot Study of a Protein Profile Test in Ovarian Cancer Patients in Remission to See if Protein Changes Can Predict Relapse be Predictive of Cancer Relapse | View | |
| NCT02307422 | Genetic Polymorphisms Associated With CAD | View | |
| NCT02642159 | Efficacy and Safety of Alirocumab Versus Usual Care on Top of Maximally Tolerated Statin Therapy in Patients With Type 2 Diabetes and Mixed Dyslipidemia ODYSSEY DM-Dyslipidemia | View | |
| NCT05330819 | Thrombogenicity of Lipoprotein A Laboratory Study Defining the Prothrombotic Effects of Lipoprotein A | View | |
| NCT00004466 | Pilot Study of Atorvastatin in Children With Chronic Hyperlipidemia Secondary to Nephrotic Syndrome | View | |
| NCT00001536 | Issues Surrounding Prenatal Genetic Testing for Achondroplasia | View | |
| NCT00387595 | Family Atherosclerosis Counseling and Testing Project | View | |
| NCT00408278 | Treatment of Newly Diagnosed Patients With Acute Promyelocytic Leukemia PETHEMA LPA 2005 | View | |
| NCT02992301 | Assessment of Atherosclerotic Plaque Characteristics Change by DCE-MRI With Alirocumab | View | |
| NCT03156621 | Study in Participants With Homozygous Familial Hypercholesterolemia HoFH | View | |
| NCT03829046 | The Effects of Evolocumab in Patients With Diabetes and Atherosclerotic Vascular Disease | View |